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Background
Diet-induced	obesity	and	food	allergies	increase	in	tandem,	but	a	potential	cause-and-effect	relationship	between	these	diseases	of	affluence	remains	to	be	tested.
Objective
We	sought	to	test	the	role	of	high	dietary	fat	intake,	diet-induced	obesity,	and	associated	changes	in	gut	microbial	community	structure	on	food	allergy	pathogenesis.
Methods
Mice	were	fed	a	high-fat	diet	(HFD)	for	12	weeks	before	food	allergen	sensitization	on	an	atopic	dermatitis–like	skin	lesion,	followed	by	intragastric	allergen	challenge	to	induce	experimental	food	allergy.	Germ-free
animals	were	colonized	with	a	signature	HFD	or	lean	microbiota	for	8	weeks	before	induction	of	food	allergy.	Food-induced	allergic	responses	were	quantified	by	using	a	clinical	allergy	score,	serum	IgE	levels,	serum	mouse
mast	cell	protease	1	concentrations,	and	 type	2	cytokine	responses.	Accumulation	of	 intestinal	mast	cells	was	examined	by	using	 flow	cytometry	and	chloroacetate	esterase	 tissue	staining.	Changes	 in	 the	gut	microbial
community	structure	were	assessed	by	using	high-throughput	16S	ribosomal	DNA	gene	sequencing.
Results
HFD-induced	obesity	potentiates	food-induced	allergic	responses	associated	with	dysregulated	intestinal	effector	mast	cell	responses,	increased	intestinal	permeability,	and	gut	dysbiosis.	An	HFD-associated	microbiome
was	transmissible	to	germ-free	mice,	with	the	gut	microbial	community	structure	of	recipients	segregating	according	to	the	microbiota	input	source.	Independent	of	an	obese	state,	an	HFD-associated	gut	microbiome	was
sufficient	to	confer	enhanced	susceptibility	to	food	allergy.
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The	past	few	decades	have	witnessed	a	continuous	increase	in	the	incidence	and	severity	of	food	allergies,	suggesting	that	modern	lifestyle	choices	can	promote	disease	in	genetically	susceptible	subjects.1
Various	hypotheses	have	been	 formulated	 to	 explain	 this	 phenomenon,	with	 the	hygiene	hypothesis	 and	diet	 hypotheses	 attracting	 the	most	 attention.2,3	Reduced	exposure	 to	 environmental	microorganisms	and
changes	 in	our	dietary	habits	 associated	with	a	Western	 lifestyle	have	been	discussed	as	potential	drivers	of	 this	 epidemiologic	 trend.4-8	 Although	a	modern	diet	might	 ensure	protection	 from	micronutrient	 and
macronutrient	deficiencies,	overindulgence	in	refined	sugars	and	saturated	fat	can	contribute	to	the	ever-growing	increase	in	immune-mediated	disorders,	including	allergies.9	Despite	epidemiologic	data	identifying	a
link	between	obesity	and	allergic	inflammation,10-13	how	diet	and	obesity	can	influence	food	allergy	remains	to	be	tested.
A	potential	link	between	diet	and	food	allergy	is	the	intestinal	microbiota.	Consumption	of	a	Western	diet	has	a	profound	effect	on	our	gut	ecosystems.14-20	Dietary	intake	of	high-fat,	high-sugar,	low-fiber	foods
along	with	therapeutic	use	of	antibiotics	perturbs	naturally	selected	host-microbe	interactions.21-25	Given	that	the	microbiota	is	involved	in	regulation	of	numerous	aspects	of	normal	host	physiology,	changes	in	this
intimate	host-microbe	interaction	might	have	long-term	consequences	for	the	regulation	of	immunity.26-31	Many	studies	have	clearly	defined	a	relationship	between	alterations	in	the	gut	microbial	community	structure
and	 allergic	 disorders,	 such	 as	 food	 allergy.32,33	 Independently,	 recent	 advances	 in	microbiome	 biology	 have	 identified	 that	 dietary	 changes	 promote	microbial	 alterations	 associated	 with	 obesity	 and	metabolic
derangements.34-37	Importantly,	changes	in	core	microbial	community	structure	associated	with	obesity	or	food	allergy	have	been	demonstrated	to	confer	a	disease	phenotype,	highlighting	the	pathogenic	role	of	a
dysbiotic	state	in	these	settings.21,27,32,33	However,	whether	high-fat	diet	(HFD)–induced	changes	in	the	gut	microbiome	influence	food	allergy	susceptibility	remains	unknown.	Furthermore,	whether	such	changes	in
the	gut	microbial	community	structure	regulate	allergic	disease	through	alteration	of	host	metabolism	or	through	direct	effects	on	the	host's	immune	system	remains	unclear.	Thus	the	focus	of	the	current	study	was
to	clearly	define	how	diet	and	associated	gut	microbial	alterations	influence	food	allergy.
To	do	so,	we	used	a	previously	established	model	of	intestinal	food	allergy	and	manipulated	dietary	composition	using	a	well-defined	model	of	HFD	feeding.38-42	Using	high-throughput	16S	rDNA	sequencing,	we
assessed	gut	microbial	community	structure	in	response	to	HFD	feeding	and	in	the	setting	of	experimental	food	allergy.	Finally,	we	examined	whether	HFD-induced	changes	in	the	gut	commensal	community	structure
alter	susceptibility	to	food	allergy.	Taking	these	unique	approaches,	we	identified	that	HFD-induced	gut	microbial	alterations	promote	food	allergy	independently	of	obesity.
Methods
Mice
Age-,	 sex-,	 and	 strain-matched	 control	mice	were	 used	 in	 all	 experiments.	Wild-type	 specific	 and	 opportunistic	 pathogen-free	C57BL/6J	mice	were	 provided	by	 Janvier	 Labs	 (Paris,	 France)	 and	housed	under	 specific	 and
opportunistic	pathogen-free	conditions	at	the	central	animal	facility	of	the	Medical	School	of	the	University	of	Bern.	For	diet-induced	obesity,	mice	were	fed	an	HFD	(45	kcal%	fat,	D12451i;	Research	Diets,	New	Brunswick,	NJ)	for	up	to
12	weeks	before	induction	of	experimental	food	allergy.	Control	groups	were	fed	a	standard	autoclavable	rodent	chow	(standard	chow	diet	[SCD];	4.5	kcal%	fat;	Provimi	Kliba	SA,	Penthalaz,	Switzerland)	or	a	matched	diet	(10	kcal%	fat,
D12450H;	Research	Diets).	All	diets	were	gamma-irradiated	(10-20	kGy).	For	microbiota	transfer	studies,	4-week-old	germ-free	(GF)	mice	were	cohoused	with	mice	fed	an	HFD	or	SCD	diet	for	8	weeks	before	induction	of	food	allergy.
All	animal	experiments	were	performed	in	compliance	with	Swiss	Federal	regulations.
Experimental	food	allergy
Mice	were	treated	daily	with	2	nmol	of	MC903	(calcipotriol;	Tocris	Bioscience,	Bristol,	United	Kingdom)	in	20	μL	of	100%	EtOH	on	both	ears	(apical	surface)	in	the	presence	of	100	μg	of	ovalbumin	(OVA)	for	14	consecutive	days
to	induce	experimental	food	allergy.	As	a	vehicle	control,	the	same	volume	of	EtOH	and	OVA	was	applied.	All	mice	were	starved	for	12	hours	before	intragastric	antigen	challenge	with	50	mg	of	OVA	on	days	14	and	17.5	and	killed
12	hours	after	the	final	oral	antigen	challenge.	Starting	20	minutes	after	oral	gavage,	mice	were	individually	observed	for	a	period	of	30	minutes,	and	a	clinical	allergy	score	was	assessed	(see	Table	E1	in	this	article's	Online	Repository
Conclusion
These	findings	identify	HFD-induced	microbial	alterations	as	risk	factors	for	experimental	food	allergy	and	uncouple	a	pathogenic	role	of	an	HFD-associated	microbiome	from	obesity.	Postdieting	microbiome	alterations
caused	by	overindulgence	of	dietary	fat	might	increase	susceptibility	to	food	allergy.
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at	www.jacionline.org).	Investigators	were	blind	to	treatment	group	conditions	when	scoring	for	allergy	symptoms.	Ear	thickness	was	measured	after	treatment	by	measuring	the	entire	width	of	the	ear	at	the	widest	point	in	microns
from	the	top	of	one	stratum	corneum	to	the	top	of	the	stratum	corneum	on	the	opposite	side	of	the	ear.
Isolation	of	cells
At	 necropsy,	 single-cell	 suspensions	 of	 skin-draining	 lymph	nodes	 (SLNs)	were	 prepared	by	 passing	 through	70-μm	nylon	mesh	 filters.	 Small	 intestinal	 lamina	 propria	 cells	were	 isolated	 by	 thoroughly	washing	 the	 small
intestines	in	PBS	and	incubating	for	10	minutes	at	37°C	with	5	mL	of	epithelial	stripping	buffer	containing	5	mmol/L	EDTA,	2	mmol/L	dithiothreitol,	and	5%	FCS	in	PBS	solution	with	shaking.	Samples	were	thoroughly	vortexed,	and
remaining	tissues	were	digested	in	5	mL	of	serum-free	medium	containing	1	mg/mL	collagenase	type	IV	(Sigma,	St	Louis,	Mo)	and	10	U/mL	DNase	I	(Roche,	Mannheim,	Germany)	for	30	minutes	at	37°C	on	an	orbital	shaker.	Digested
tissues	were	passed	through	70-μm	nylon	mesh	filters,	and	single-cell	suspensions	were	stained	with	biotin	anti-mouse	epithelial	cell	adhesion	molecule	(G8.8;	BioLegend,	San	Diego,	Calif)	for	targeted	removal	of	epithelial	cells	with
Streptavidin	RapidSpheres	and	separation	with	an	EasySep	magnet	(STEMCELL	Technologies,	Vancouver,	British	Columbia,	Canada).
Flow	cytometry
Single-cell	suspensions	of	indicated	tissues	were	incubated	with	Aqua	Live/Dead	Fixable	Dye	(Invitrogen,	Carlsbad,	Calif)	for	dead	cell	exclusion	and	stained	with	anti-mouse	fluorochrome-conjugated	mAbs	against	CD3ε	(145-
2C11),	CD4	(GK1.5),	CD5,	CD8,	CD19	(1D3),	NK1.1	(PK136),	CD19	(6D5),	IgE,	CD45	(30-F11),	CD49b	(DX5),	c-Kit	(2B8),	and	FcεRI	(Mar-1).	Intestinal	mast	cells	were	identified	as	live	Lin−	(CD3−CD5−CD19−NK1.1−),	CD45+,	c-Kit+,
and	IgE+	cells.	Intestinal	eosinophils	were	identified	as	live	Lin−,	CD45+,	side	scatter–high,	and	Siglec-F+	cells,	and	skin	basophils	were	identified	as	live	Lin−,	CD45+,	and	c-Kit−	cells	coexpressing	CD49b	and	IgE.	All	samples	were
acquired	on	an	LSRII	(BD	Biosciences,	San	Diego,	Calif)	and	analyzed	with	FlowJo	software	(TreeStar,	Ashland,	Ore).
Cell	stimulation
Single-cell	suspensions	 from	SLNs	were	cultured	with	100	μg	of	pyrogen-free	OVA	(Hyglos,	Bernried	am	Starnberger	See,	Germany)	 for	96	hours	 in	complete	media	 (RPMI	1640	containing	10%	FCS,	100	U/mL	penicillin,
100	μg/mL	streptomycin,	2	mg/mL	L-glutamine,	and	25	mmol/L	HEPES).	Cell-free	supernatants	were	collected	for	determination	of	type	2	cytokine	protein	levels	by	using	a	standard	sandwich	ELISA.
ELISA,	histology,	RNA	isolation,	and	quantitative	real-time	RT-PCR
Measurement	of	levels	of	mouse	mast	cell	protease	1	(MMCP-1)	in	serum	was	performed	according	to	a	commercially	available	DuoSet	ELISA	kit	(eBioscience,	San	Diego,	Calif).	Total	and	antigen-specific	serum	IgE	responses
were	measured,	as	described	previously.40
For	histologic	analysis,	tissues	were	fixed	in	4%	paraformaldehyde	and	embedded	in	paraffin,	and	sections	were	stained	with	hematoxylin	and	eosin	(H&E).	H&E-stained	epididymal	adipose	tissue	sections	were	digitalized	by
using	the	Pannoramic	250	Flash	III	(3DHISTECH,	Budapest,	Hungary)	whole-slide	scanner	equipped	with	a	×20	objective.	H&E-stained	epididymal	adipose	tissues	were	analyzed	by	determining	the	area	of	each	adipocyte	in	the	field
(×20	magnification).	Three	 fields	were	 randomly	 selected	 for	analysis	 from	each	 tissue	 section	 from	each	mouse.	Adipocytes	were	categorized	by	 size,	 and	 the	average	number	of	 adipocytes	per	 size	was	determined.	Data	were
expressed	as	the	frequency	of	adipocytes	in	each	size	category	compared	with	the	total	number	of	adipocytes	counted.
Intestinal	mast	cells	were	stained	with	Naphtol	AS-D	Chloroacetate–specific	esterase	(Sigma	Aldrich),	according	to	the	manufacturer's	instructions.	Tissue	samples	were	homogenized	in	TRIzol	with	a	TissueLyser	(Qiagen),	and
RNA	was	isolated	by	using	phenol	chloroform	extraction	and	isopropanol	precipitation.	cDNA	was	generated	with	the	High	Capacity	Reverse	Transcription	Kit	(Applied	Biosystems,	Foster	City,	Calif).	RT-PCR	was	performed	by	using
commercially	available	QuantiTect	primer	assays	(Qiagen).	Data	were	analyzed	by	using	the	ΔΔ	cycle	threshold	method	whereby	β-actin	served	as	an	endogenous	control.	All	samples	were	run	with	RT	SYBR	Green	on	an	Applied
Biosystems	7900HT	Fast	Real-time	PCR	system.
Intestinal	permeability
Intestinal	permeability	was	assessed	by	using	fluorescein	isothiocyanate	(FITC)–Dextran	accumulation	in	serum.	Mice	were	fasted	for	4	hours	before	oral	gavage	with	60	mg/100	g	mouse	4-kDa	FITC-Dextran	(Sigma-Aldrich).
Four	hours	after	oral	gavage,	blood	was	collected	by	means	of	cardiac	puncture,	stored	on	 ice	 in	 the	dark,	and	centrifuged	at	10,000g	 for	10	minutes.	Serum	was	diluted	1:10	 in	PBS,	and	 the	concentration	of	FITC-Dextran	was
determined	by	using	fluorescence	spectroscopy	(excitation	at	485	nm	and	emission	at	535	nm).	For	calculation	of	a	linear	standard	curve,	FITC-Dextran	was	serially	diluted	in	sera	of	naive	mice.43
Bacterial	DNA	isolation	and	16S	rDNA	gene	sequence	analysis
Stool	samples	from	individual	mice	were	collected	fresh	into	sterile	2-mL	microcentrifuge	tubes	at	the	indicated	time	points,	snap-frozen,	and	stored	at	−80°C	until	DNA	isolation.	Fecal	genomic	DNA	was	prepared	by	using	the
QIAamp	Fast	DNA	Stool	Mini	Kit	(Qiagen),	according	to	the	manufacturer's	instructions,	with	minor	modifications.	Additional	homogenization	(glass	beads	at	30	Hz	for	3	minutes)	and	lysis	were	performed	(20	mg/mL	Lysozyme	[Sigma-
Aldrich],	20	mmol/L	Tris	HCl	[pH	8.0],	2	mmol/L	EDTA,	and	1.2%	triton	autoclaved)	to	improve	the	quality	and	quantity	of	DNA	from	both	gram-negative	and	gram-positive	bacteria.	Fecal	DNA	was	then	extracted	according	to	the	Kit
protocol	(QIAmp	Fast	DNA	Stool	Mini	Kit,	Qiagen).	The	concentration	and	purity	of	the	isolated	DNA	were	evaluated	by	using	NanoDrop	and	Bioanalyzer	(Thermo	Scientific,	Waltham,	Mass).	PCR	amplification	of	16S	rDNA	genes	with
primers	specific	for	the	V4	domain	of	bacterial	rDNA	(341F_ill:	CCTACGGGNGGCWGCAG	and	802R_ill:	GACTACHVGGGTATCTAATCC),	purification	of	PCR	products,	library	preparation,	and	sequencing	on	the	Illumina	MiSeq	system
were	performed	by	Microsynth	AG	(Balgach,	Switzerland).
Raw	reads	were	quality	filtered	with	FastX-Tools	(-Q	33,	-p	75),	merged	with	PEAR	(-m	360	-n	100	-j	4-q	26	-v	50	-b	33;	Zhang	et	al,	2014)Raw	reads	were	quality-filtered	with	FastX-Tookit	(a	minimum	quality	score	of	33	kept	across	75%	of	the
bases),	merged	with	PEAR	(with	a	maximum	possible	length	of	merged	reads	of	360,	minimum	possible	length	of	merged	reads	of	100,	score	quality	threshold	for	trimming	of	26,	minimum	overlap	size	of	50,	and	a	base	PHRED	quality	score	of	33	and
filtered	again	with	VSEARCH	fastq	_filter.	Reads	were	dereplicated	(-minuniquesize	2),	clustered	at	0.97	 identity,	and	chimera	 filtered	with	VSEARCH.44	Filtered	reads	were	 then	mapped	back	 to	 the	 final	clusters	with	VSEARCH
—usearch_global.	The	resulting	operational	taxonomic	unit	(OTU)	table	was	normalized	by	using	total	DNA	extraction	yields,	and	samples	with	low	output	values	were	excluded	from	the	analysis.	Representative	sequences	(centroids)
from	each	cluster	were	classified	with	SINA	against	the	SILVA_132_NR99	database,45	and	composition	was	explored	by	using	PHINCH.46	Differences	between	treatments	were	detected	with	the	Welch	2-sided	test,	and	significantly
different	 taxa	were	considered	when	the	P	 value	was	 less	 than	 .05	 (corrected	with	 the	Storey	 false	discovery	 rate)	and	effect	 sizes	were	greater	 than	1	 for	differences	between	proportions	and	greater	 than	2	 for	 ratios	between
proportions.	Statistical	differences	were	calculated	with	STAMP.47	Normalized	OTU	tables	were	used	to	calculate	rarefactions,	richness	(total	OTU	number),	and	the	Shannon	index.	A	Hellinger-corrected	Bray-Curtis	similarity	matrix
was	used	to	calculate	an	nonmetric	multidimensional	scaling	(NMDS)	and	a	cluster	analysis,	and	both	ADONIS	and	ANOSIM	were	used	to	test	for	differences	between	treatments.	All	calculations	were	done	in	the	R	package	VEGAN.
Statistical	analysis
Except	for	the	16S	rDNA	gene	sequence	analyses,	all	data	were	analyzed	with	GraphPad	Prism	6	software	(GraphPad	Software,	La	Jolla,	Calif).	Results	are	shown	as	means	±	SEMs.	Statistical	significance	was	determined	by
using	the	Student	t	test	or	1-way	ANOVA	with	the	Tukey	or	Dunn	multiple	comparison	tests.	Results	were	considered	significant	at	P	values	of	.05	or	less.	The	number	of	experiments	performed	is	indicated	at	the	end	of	each	figure
legend.
Results
High	dietary	fat	intake	potentiates	food-induced	allergic	responses
The	 increasing	prevalence	of	obesity	and	food	allergy	provokes	the	hypothesis	 that	 these	processes	might	be	related.	Although	obesity	has	been	associated	with	 increased	IgE	responses	and	allergic	symptoms,	whether	 it
predisposes	to	an	increased	food	allergy	risk	remains	to	be	tested.48-51	To	investigate	whether	HFD	feeding	confers	an	increased	risk	of	food	allergy,	wild-type	C57BL/6J	mice	were	fed	an	HFD	(45	kcal%	fat,	D12451i;	Research	Diets),	a
matching	control	diet	(10	kcal%	fat,	D12450H;	Research	Diets),	or	an	SCD	(4.5	kcal%	fat;	Provimim	Kliba	SA)	for	12	weeks	before	induction	of	experimental	food	allergy	(Fig	1,	A).	After	establishment	of	obesity	in	the	HFD	group	(Fig	1,
B-D,	and	see	Fig	E1	in	this	article's	Online	Repository	at	www.jacionline.org),	mice	were	sensitized	to	the	model	food	antigen	OVA	on	atopic	dermatitis	(AD)–like	skin	lesions.	Then,	as	previously	described,38,40	mice	were	challenged
intragastrically	with	OVA	to	induce	food	allergy.	This	resulted	in	phenotypic	features	of	food	allergy,	as	characterized	by	an	increased	clinical	food	allergy	score	(Fig	1,	E),	total	and	antigen-specific	IgE	responses	(Fig	1,	F	and	G),	and
serum	MMCP-1	levels	(Fig	1,	H).	In	contrast	to	mice	with	food	allergy	fed	an	SCD,	mice	with	food	allergy	fed	an	HFD	exhibited	an	increased	food	allergy	score	(Fig	1,	E)	and	increased	serum	MMCP-1	levels	(Fig	1,	H),	whereas	no
significant	changes	in	total	and	allergen-specific	serum	IgE	levels	were	observed	between	treatment	groups	(Fig	1,	F	and	G).	Importantly,	mice	fed	a	matched	control	diet	exhibited	similar	allergic	responses	than	mice	with	food	allergy
fed	an	SCD	(see	Fig	E2	in	this	article's	Online	Repository	at	www.jacionline.org).
Together,	our	data	indicate	that	prolonged	feeding	of	an	HFD	associated	with	obesity	increased	susceptibility	to	experimental	food	allergy.
HFD	does	not	alter	AD-like	skin	inflammation	and	food	allergen	sensitization
To	test	whether	enhanced	food	allergy	in	HFD-fed	mice	was	simply	secondary	to	enhanced	skin	inflammation,	cutaneous	food	allergen	sensitization,	or	both,	we	first	assessed	the	development	of	AD-like	skin	lesions	in	response
to	topical	calcipotriol	(MC903)	and	OVA	treatment	in	mice	fed	an	SCD	or	HFD.	Skin	inflammation	was	assessed	based	on	histology	(Fig	2,	A),	ear	swelling	(Fig	2,	B),	and	infiltration	of	total	leukocytes	(Fig	2,	C)	and	basophils	(Fig	2,	D),
which	were	previously	shown	to	promote	AD-like	skin	lesions	and	cutaneous	food	allergen	sensitization	in	this	model	system.38,40	However,	irrespective	of	disease	state	and	the	diet	fed,	no	differences	on	all	parameters	assessed	were
observed	(Fig	2,	A-D).
Fig	1	Diet-induced	obesity	potentiates	food-induced	allergic	responses.	A,	Experimental	protocol.	i.g.,	Intragastric.	B,	WAT	weight	of	percentage	body	weight.	C,	H&E	staining	of	WAT.	Scale	bar	=	100	μm.	D,	Distribution	of	adipocyte	size	of	WAT,	as	determined	by	using
histomorphometric	analyses.	E,	Clinical	allergy	score	of	control	mice	and	mice	with	food	allergy	(MC903	and	OVA)	fed	an	SCD	or	HFD.	F	and	G,	Total	(Fig	1,	F)	and	OVA-specific	(Fig	1,	G)	serum	IgE	levels.	H,	Serum	MMCP-1	levels.	Data	are	representative	of	4	independent
experiments	with	4	to	6	mice	per	group.	Solid	bars	represent	mice	fed	an	SCD,	and	open	bars	represent	HFD-fed	mice.	Error	bars	indicate	means	±	SEMs.	ND,	No	disease;	ns,	not	significant.	*P	<	.05,	**P	<	.01,	***P	<	.005,	and	****P	<	.001.
To	study	 the	 role	of	HFD	and	associated	obesity	on	cutaneous	 food	allergen	 sensitization,	we	next	assessed	production	of	 the	canonical	 type	2	cytokines	 IL-4,	 IL-5,	 and	 IL-13	 in	 cell-free	culture	 supernatants	of	 allergen-
restimulated	SLN	cells.	Although	food	allergen	sensitization	on	AD-like	skin	resulted	in	robust	allergen-specific	type	2	immune	responses	in	SLNs,	no	significant	changes	were	observed	in	mice	fed	either	an	SCD	or	an	HFD	(Fig	2,	E).
Together,	these	data	demonstrate	that	HFD	and	obesity	do	not	directly	affect	the	development	of	AD-like	skin	inflammation	and	the	magnitude	of	associated	cutaneous	food	allergen	sensitization	in	this	experimental	setting.
HFD	promotes	mucosal	mast	cell	accumulation	and	increases	intestinal	permeability
Given	 the	 absence	 of	 an	 effect	 on	 cutaneous	 inflammation	 and	 sensitization	 (Fig	 2)	 but	 increased	 systemic	 levels	 of	mast	 cell	 proteases	 (Fig	 1,	H),	 we	 hypothesized	 that	 effector	 mast	 cells	 in	 the	 intestine	 can	 become
dysregulated	in	the	setting	of	food	allergy	associated	with	HFD.	To	test	this,	we	first	examined	whether	there	were	differences	in	mast	cell	frequencies	and	numbers	in	the	intestines	of	SCD-	and	HFD-fed	nonallergic	mice	(EtOH	plus
OVA)	and	found	no	differences	across	groups	(Fig	3,	A-C).	Strikingly,	when	experimental	food	allergy	was	induced	in	both	SCD-	and	HFD-fed	mice	(MC903	plus	OVA),	there	was	a	significant	increase	in	intestinal	mast	cell	accumulation
in	HFD-fed	mice	compared	with	control	animals,	whereas	no	significant	changes	in	eosinophil	frequencies	and	numbers	were	observed	(Fig	3,	A-C).	Visualization	and	enumeration	of	chloroacetate	esterase–positive	mast	cells	in	small
intestinal	tissue	sections	corroborated	flow	cytometric	findings	with	HFD	feeding,	potentiating	food	allergy–related	intestinal	mast	cell	accumulation	(Fig	3,	D	and	E).
Fig	2	HFD	does	not	alter	AD-like	skin	inflammation	and	cutaneous	food	allergen	sensitization.	A,	H&E	staining	of	the	skin	of	control	mice	(EtOH	plus	OVA)	or	mice	with	food-induced	allergy	(MC903	plus	OVA)	fed	an	SCD	or	HFD.	Scale	bar	=	100	μm.	B,	Ear	swelling.	C	and	D,
Frequencies	of	total	leukocytes	(Fig	2,	C)	and	skin	basophils	(Fig	2,	D).	Basophils	were	gated	as	live	CD45+,	Lin−	(CD3−CD5−CD19−NK1.1−),	and	c-Kit−	cells	coexpressing	CD49b	and	IgE.	E,	Type	2	cytokine	production	in	cell-free	supernatants	of	antigen-restimulated	SLN	cultures.
Data	are	representative	of	3	individual	experiments	with	4	to	6	mice	per	group.	Error	bars	indicate	means	±	SEMs.	nd,	Not	detectable;	ns,	not	significant.	*P	<	.05	and	**P	<	.01.
We	next	tested	whether	enhanced	mast	cell	accumulation	and	associated	release	of	mast	cell–specific	proteases	might	further	promote	reported	HFD-induced	intestinal	permeabilization.	Consistent	with	previous	reports,14,52,53
Fig	3	HFD	feeding	potentiates	food	allergy–related	mucosal	mast	cell	accumulation	and	increases	intestinal	permeability.	A,	Representative	fluorescence-activated	cell	sorting	plots	of	mast	cells	and	eosinophils	in	the	small	intestinal	lamina	propria	of	control	mice	(EtOH	plus	OVA)	or
mice	with	food	allergy	(MC903	plus	OVA)	fed	an	SCD	or	HFD.	B,	Quantification	of	mast	cell	and	eosinophil	frequencies	in	the	small	intestinal	lamina	propria.	For	quantification,	mast	cells	were	gated	as	live	CD45+,	and	Lin−	(CD3−CD5−CD19−NK1.1−)	cells	coexpressing	c-Kit	and
IgE.	Eosinophils	were	gated	as	live	CD45+,	Lin−	(CD3−CD5−CD19−NK1.1−)	Siglec-F+,	and	side	scatter–high	cells.	C,	Quantification	of	total	mast	cell	and	eosinophil	numbers	in	the	small	intestinal	lamina	propria.	D,	Chloroacetate	esterase	staining	of	mast	cells	from	the	jejunum.
Scale	bar	=	100	μm.	E,	Quantification	of	chloroacetate	esterase–positive	mast	cells	per	high-powered	field	(hpf).	F,	FITC-Dextran	concentration	in	serum	of	mice	with	food	allergy	fed	an	SCD	or	HFD.	G-I,	Gene	expression	levels	of	the	tight	junction	genes	Ocln,	Tjp1	and	Cldn2	in	the
small	intestines	of	SCD-	or	HFD-fed	mice	with	food	allergy.	Solid	bars	represent	mice	fed	an	SCD,	and	open	bars	represent	HFD-fed	mice.	Data	in	Fig	3,	A-E	and	G-I,	are	representative	of	4	independent	experiments	(pooled)	with	4	to	6	mice	per	group.	Data	in	Fig	3,	F,	are
representative	of	2	individual	experiments	with	5	to	8	mice	per	group.	Error	bars	indicate	means	±	SEMs.	ns,	Not	significant.	*P	<	.05,	**P	<	.01,	***P	<	.005,	and	****P	<	.001.
we	found	that	HFD	feeding	altered	intestinal	permeability,	as	assessed	by	an	in	vivo	FITC-Dextran	assay,	which	was	further	enhanced	on	induction	of	food	allergy	in	HFD-fed	mice	(Fig	3,	F,	and	data	not	shown).	Altered	intestinal	barrier
integrity	in	HFD-fed	mice	with	food	allergy	further	correlated	with	a	reduction	in	gene	expression	levels	of	occludin	(Ocln)	and	tight	junction	protein	1	(Tjp1)	and	a	significant	 increase	 in	expression	of	claudin-2	 (Cldn2),	a	channel-
forming	tight	junction	protein	expressed	predominantly	in	leaky	epithelia	(Fig	3,	G-I).	Together,	mice	with	food	allergy	fed	an	HFD	presented	with	dysregulated	intestinal	mast	cell	responses	and	increased	intestinal	permeabilization
that	can	promote	facilitated	passage	of	allergens	to	perpetuate	intestinal	allergic	inflammation.
HFD-induced	adiposity	and	food	allergy	are	associated	with	intestinal	dysbiosis
In	 addition	 to	 increasing	 intestinal	 barrier	 permeability,	 HFD	 feeding	 and	 associated	 obesity	 have	 been	 demonstrated	 to	 promote	 significant	 changes	 in	 the	 relative	 abundance	 and	 phylogenetic	 diversity	 of	 the	 gut
microbiota.18,54-56	Consistent	with	these	previous	reports,	16S	rDNA	amplicon	sequencing	analyses	confirmed	that	high	dietary	fat	intake	is	associated	with	pronounced	changes	in	gut	microbiota	composition	(Fig	4,	A,	and	see	Fig	E3,	A,
in	this	article's	Online	Repository	at	www.jacionline.org).	We	found	an	overall	reduction	in	α-diversity,	with	fewer	and	more	dominant	OTUs	in	mice	fed	an	HFD	compared	with	SCD-fed	control	mice,	as	assessed	based	on	the	total
number	of	OTUs	and	a	Shannon	index	result	that	is	further	compromised	in	HFD-fed	mice	with	food	allergy	(Fig	4,	B	and	C).	Using	the	Welch	test	to	detect	per-family	and	per-genera	differences	across	different	treatments,	we	observed
a	significant	 increase	 in	abundance	of	 the	 families	Ruminococcaceae	 (Clostridiales),	Desulfovibrionaceae	 (Deltaproteobacteria),	and	Rikenellaceae	 (Bacteroidetes)	and	a	 reduction	 in	abundance	of	 the	 families	Muribaculaceae	and
Prevotellaceae	in	mice	fed	an	HFD	diet	(P	<	.05,	difference	between	proportions	>	1,	ratio	between	proportions	>	2;	see	Fig	E3,	B).	The	observed	changes	in	α-diversity	in	response	to	HFD	feeding	suggest	an	increase	in	dominance	of
specific	phylotypes	(relative	abundances	of	Verrucomicrobia,	Deltaproteobacteria,	Ruminococcus	and	Lachnospiraceae	[Clostridia],	and	other	Bacteroidaceae),	a	pattern	that	is	consistent	with	previous	reports	addressing	the	effect	of
high	dietary	fat	intake	on	gut	microbiota	composition.27,57
To	assess	β-diversity	across	samples,	we	next	used	NMDS	analysis	as	a	commonly	regarded	robust	unconstrained	ordination	method	in	community	ecology.	NMDS	plots	show	a	significant	separation	of	sample	groups	according
to	dietary	manipulation	and	allergic	disease	state	(Fig	4,	D).	We	observed	that	an	HFD	modulates	the	bacterial	profile	and	draws	this	group	apart	from	the	microbiota	profile	of	mice	fed	a	control	diet.	Furthermore,	using	multivariate
analyses,	we	found	that	epididymal	fat	weight,	frequency	of	intestinal	mast	cells,	and	clinical	allergy	scores	significantly	correlate	with	microbial	clustering	patterns	with	the	length	of	the	vectors	(mast	cells	and	fat	weight)	and	sizes	of
circles	(allergy	score)	corresponding	to	the	importance	of	each	of	the	parameters	assessed	to	the	clustering	pattern.	An	average	clustering	dendrogram	of	Bray-Curtis	dissimilarities	further	demonstrates	the	distance	and	clustering	of
Fig	4	Effects	of	diet-induced	obesity	and	food	allergy	on	gut	microbiota	composition.	A,	Bacterial	relative	abundances	represented	at	the	order	level.	B,	Microbial	richness,	as	assessed	by	total	OTU	numbers.	C,	Shannon	index.	D,	NMDS	plot	of	gut	microbiota	composition,	intestinal
mast	cells,	and	adipose	tissue	weight	of	nonallergic	mice	and	mice	with	food	allergy	fed	an	SCD	or	HFD.	Animals	are	represented	by	dots,	and	treatment	is	color	coded.	Circle	size	indicates	the	magnitude	of	the	allergy	score	of	each	animal.	The	number	of	intestinal	mast	cells	and
weight	of	epididymal	fat	fitted	variables	are	represented	by	black	vectors.	Differences	between	treatments	are	supported	by	ANOSIM	and	ADONIS,	and	statistics	are	depicted	in	the	upper	panel.	E,	Average	clustering	dendrogram.	All	OTUs	in	Fig	4,	A	and	B,	show	significant
differences	(P	<	.05,	differences	between	proportions	>	1,	and	ratio	of	proportions	<	2).
individual	samples	according	to	both	dietary	modulation	and	disease	state	(Fig	4,	E).
Together,	our	multivariate	analyses	exploring	the	effect	of	an	HFD	on	gut	microbial	ecology	and	food	allergy	reveal	a	specific	HFD-specific	microbiota	signature	that	significantly	correlates	with	disease	markers	and	clinical
signs	of	experimental	food	allergy.
HFD-associated	microbiome	is	transmissible	and	durable
We	next	performed	microbiota	transplantation	experiments	to	test	a	potential	disease-promoting	role	of	a	signature	HFD	microbiota	for	the	pathogenesis	of	food	allergy.	To	do	so,	4-week-old	wild-type	C57BL6/J	GF	mice	were
horizontally	colonized	by	cohousing	GF	mice	with	microbiota	donors	fed	either	a	control	diet	(SCD)	or	an	HFD	(1	donor	plus	4	GF	mice	per	treatment	group	per	experiment,	2	independent	experiments).	Recipients	were	colonized	with
the	respective	donor	microbiotas	for	2	months	and	fed	a	control	diet	(SCD)	throughout	the	experiment	(Fig	5,	A).	We	found	that	the	microbiota	phenotype	of	HFD-fed	mice	(reduced	α-diversity	and	increased	β-diversity)	is	transmissible
to	microbiota-replete	GF	 recipients	 (Fig	5,	B-D,	 and	see	Fig	 E4	 in	 this	 article's	Online	Repository	 at	www.jacionline.org).	 Importantly,	 an	HFD	microbiota	 signature	was	 conserved	 over	 time	 in	GF	 reconstituted	mice	 fed	 an	 SCD,
suggesting	that	there	are	postdieting	differences	in	the	microbiota	composition	or	function	that	cannot	be	readily	reverted,	even	if	mice	are	returned	to	their	original	diet.	NMDS	plots	and	an	average	clustering	dendrogram	of	β-
diversity	show	that	the	microbiota	of	reconstituted	GF	mice	clustered	in	accordance	with	the	microbiota	input	source,	with	the	largest	Bray-Curtis	dissimilarities	observed	between	diet	treatment	of	the	source	communities	(P	<	.001;
Fig	5,	E	and	F).
Together,	our	microbiota	transplantation	experiments	suggest	that	an	HFD-associated	microbiome	is	transmissible	to	GF	mice	and	clusters	with	the	donor	microbiota	through	time.	Such	inherited	dietary-induced	changes	in	the
gut	microbial	community	structure	can	have	significant	functional	properties	on	host	physiology	and	immunity	independently	of	diet.
HFD-associated	microbiota	confers	enhanced	susceptibility	to	food	allergy	independently	of	obesity
Fig	5	Reconstitution	of	GF	mice	with	a	donor	lean	or	HFD-associated	microbiome.	A,	Schematic	of	microbiota	repletion	studies.	B,	Bacterial	relative	abundances	represented	at	the	order	level.	C,	Microbial	richness	as	assessed	based	on	total	OTU	numbers.	D,	Shannon	index.	E,
NMDS	plot	of	gut	microbiota	composition	of	microbiota-replete	GF	mice	colonized	with	an	SCD-	or	HFD-associated	microbiome	at	week	1	and	week	8	after	colonization.	Asterisks	indicate	colonizer	microbiomes.	Differences	between	treatments	are	supported	by	ANOSIM	and
ADONIS,	and	statistics	are	depicted	in	the	upper	panel.	F,	Average	clustering	dendrogram.	Graphs	in	Fig	5,	C-F,	show	combined	data	of	2	individual	experiments.
Although	numerous	studies	have	linked	specific	disease	states	with	changes	in	the	gut	microbiota	structure,	there	are	limited	data	demonstrating	causality.	To	explore	whether	transmission	of	the	HFD-associated	microbiota
phenotype	has	functional	implications	on	food	allergy	pathogenesis,	4-week-old	GF	mice	were	colonized	with	a	signature	control-	or	HFD-associated	microbiota	from	lean	and	obese	mice,	respectively,	for	2	months	before	induction	of
food	allergy.	In	contrast	to	previous	studies,	obesity	did	not	represent	a	transmissible	trait	in	GF	mice	reconstituted	with	a	signature	HFD	microbiota	over	the	course	of	2	months.	Irrespective	of	the	donor	microbiota	input,	microbiota-
replete	GF	mice	exhibited	comparable	weight	gain	and	epididymal	fat	mass	accumulation	over	time	(Fig	6,	A,	and	see	Fig	E5	in	this	article's	Online	Repository	at	www.jacionline.org).	Furthermore,	histologic	analyses	of	adipocyte	size	in
epididymal	 adipose	 tissue	 did	 not	 reveal	 differences	 between	 SCD-	 or	HFD	microbiome-associated	 food	 allergic	mice.	 (Fig	 6,	B	 and	C).	 Intriguingly,	 we	 find	 that	 increased	 susceptibility	 to	 food	 allergy	 in	mice	 fed	 an	HFD	was
transmissible	to	GF	mice	when	reconstituted	with	a	donor	HFD	microbiota.	GF	mice	reconstituted	with	a	signature	HFD	microbiota	exhibited	increased	food-induced	allergic	responses	compared	with	control	mice	(GF	mice	colonized
with	a	signature	lean	microbiota),	as	characterized	by	increased	serum	IgE	levels	(Fig	6,	D	and	E),	increased	MMCP-1	levels	(Fig	6,	F),	type	2	intestinal	cytokine	responses	(Fig	6,	G),	and	accumulation	of	effector	mast	cells	to	the	small
intestinal	lamina	propria,	as	assessed	by	using	flow	cytometry	(Fig	6,	H)	and	chloroacetate	esterase	tissue	staining	(Fig	6,	I	and	J).
Fig	6	An	HFD-associated	microbiome	confers	enhanced	susceptibility	to	food	allergy.	A,	WAT	weight	of	percentage	body	weight	of	GF	mice	reconstituted	with	an	SCD-	or	HFD-associated	microbiome.	B,	H&E	staining	of	WAT.	Scale	bar	=	100	μm.	C,	Distribution	of	adipocyte	size	of
WAT,	as	determined	by	using	histomorphometric	analyses.	D	and	E,	Total	(Fig	6,	D)	and	OVA-specific	(Fig	6,	E)	serum	IgE	levels	in	ex-GF	mice	with	food	allergy	reconstituted	with	an	SCD-	or	HFD-associated	microbiome.	F,	Serum	MMCP-1	levels.	G,	Relative	gene	expression	levels	of
Il13	in	the	small	intestine.	H,	Mast	cell	numbers	in	the	small	intestinal	lamina	propria,	as	assessed	by	using	flow	cytometry.	I,	Chloroacetate	esterase	staining	of	mast	cells	from	the	jejunum.	Scale	bar	=	100	μm.	J,	Quantification	of	chloroacetate	esterase–positive	mast	cells	per	high-
powered	field	(hpf).	Data	are	representative	of	2	independent	experiments	with	4	to	5	mice	per	group.	Solid	bars	represent	GF	mice	reconstituted	with	an	SCD-associated	microbiome,	and	open	bars	represent	HFD	microbiome–reconstituted	mice.	Error	bars	indicate	means	±	SEMs.
ns,	Not	significant.	*P	<	.05,	**P	<	.01,	***P	<	.005,	and	****P	<	.001.
Together,	our	studies	demonstrate	that	a	microbiota	signature	associated	with	high	dietary	fat	intake	has	disease-promoting	properties	by	conferring	increased	susceptibility	to	experimental	food	allergy	independently	of	an
obese	phenotype.
Discussion
The	present	study	provides	several	conceptual	advances	in	our	understanding	of	a	potential	correlation	between	high	dietary	fat	intake,	obesity,	and	food	allergy.	First,	we	report	that	HFD	feeding	promotes	intestinal	mast	cell
dysregulation	in	the	setting	of	food	allergy.	Second,	we	demonstrate	that	high	dietary	fat	intake	decreases	microbial	diversity,	a	trait	that	is	both	transmissible	and	durable.	Third	and	finally,	HFD-associated	dysbiosis	confers	enhanced
susceptibility	to	food	allergy	independently	of	obesity.	Collectively,	our	findings	indicate	that	high	dietary	fat	 intake	enhances	susceptibility	to	food	allergy	and	that	this	effect	 is	mediated	by	durable	postdieting	changes	in	the	gut
microbiome.
A	Western	diet	rich	in	unsaturated	fats	and	refined	sugars	has	been	hypothesized	as	a	contributing	factor	to	the	surge	in	allergies	in	pediatric	patients.58,59	Furthermore,	several	clinical	studies	have	demonstrated	a	positive
correlation	of	body	mass	index	with	IgE	levels	and	a	greater	incidence	of	atopy	in	obese	children.60,61	However,	how	diet	and	obesity	predispose	to	allergic	disorders	remains	ill-defined.
Here	we	 demonstrate	 that	 high	 dietary	 fat	 intake	 enhances	 food	 allergy.	 Although	HFD	 feeding	 had	 no	 effect	 on	 intestinal	mast	 cells	 at	 steady	 state,	 induction	 of	 allergic	 inflammation	 in	 this	 setting	 resulted	 in	 robust
accumulation	of	mucosal	mast	cells,	which	has	previously	been	shown	to	correlate	with	disease	severity.37	However,	the	mechanisms	by	which	mast	cells	expand	in	the	setting	of	HFD	feeding	and	food	allergy	remain	poorly	defined.
Previous	studies	suggested	white	adipose	tissue	(WAT)	as	a	dedicated	reservoir	of	mast	cell	progenitors	(MCps)	that	have	the	capacity	to	migrate	to	distant	organs,	such	as	the	intestine.62	Although	HFD	feeding	in	our	experimental
settings	 did	 not	 alter	 MCps	 in	 the	 intestine	 (data	 not	 shown),	 we	 found	 a	 significant	 increase	 in	 numbers	 of	 MCps	 in	 WAT	 of	 HFD-fed	 mice	 compared	 with	 control	 mice	 (see	 Fig	 E6	 in	 this	 article's	 Online	 Repository	 at
www.jacionline.org).	It	is	likely	that	in	the	context	of	HFD	feeding	and	subsequent	induction	of	experimental	food	allergy,	WAT-derived	MCps	migrate	to	sites	of	allergic	inflammation.	However,	additional	studies	are	required	to	support
an	MCp	WAT-gut	axis	in	the	context	of	HFD	feeding.
Our	findings	demonstrating	that	HFD	feeding	induces	gut	dysbiosis,	which	in	term	promotes	food	allergy,	suggest	that	commensal	alterations	result	in	modulation	of	mast	cell	proliferation,	recruitment,	or	both.	It	is	possible
that	this	occurs	either	directly	or	indirectly	through	effects	on	other	cells	caused	by	alterations	in	metabolites,	such	as	the	availability	of	short-chain	fatty	acids.	Indeed,	recently,	it	has	been	shown	that	short-chain	fatty	acids	promote
intestinal	regulatory	T	cells	to	inhibit	mast	cell	expansion	and	degranulation.54
Yet	another	mechanism	that	might	explain	exaggerated	mast	cell	accumulation	in	mice	with	food	allergy	fed	an	HFD	could	involve	IgE	binding	on	mast	cells.	Importantly,	reduced	gut	microbial	diversity,	as	observed	in	HFD-fed
mice,	has	been	associated	with	hyper-IgE	responses.63,64	Despite	the	induction	of	allergen-specific	IgE	responses	in	control-	and	HFD-fed	mice	with	food	allergy	being	comparable,	total	serum	IgE	levels	were	increased	in	obese	mice
with	food	allergy	but	did	not	reach	statistical	significance.	Nevertheless,	increased	total	IgE	responses	in	mice	with	food	allergy	fed	an	HFD	can	stabilize	mast	cell	function	and	survival,	thus	explaining	exaggerated	mucosal	mast	cell
accumulation	in	HFD-fed	mice	with	food	allergy.65	However,	future	studies	will	be	required	to	determine	how	HFD-associated	dysbiosis	promotes	mast	cell	accumulation	in	the	intestines	of	mice	with	food	allergy.
Consistent	with	 previous	 reports,	HFD	 feeding	 in	 our	 experimental	 settings	was	 associated	with	 a	 significant	 decrease	 in	 α-diversity,	with	 increased	 relative	 abundance	 of	 specific	 phylotypes,	 including	 Verrucomicrobia,
Deltaproteobacteria,	Ruminococcus,	Lachnospiraceae	(Clostridia),	and	other	Bacteroidaceae.27,57	Although	HFD	feeding	has	been	demonstrated	to	promote	significant	changes	to	the	gut	microbial	community	structure	within	a	few
days,	 such	dietary-induced	changes	 to	 the	gut	microbiota	can	be	partially	 reversed	by	subsequent	 low-fat,	high-fiber	dietary	manipulations.18	However,	 long-term	dietary	 interventions	can	 irreversibly	disrupt	a	core	gut	microbial
community	structure	with	long-lasting	consequences	for	the	host.	In	our	experimental	settings	we	found	that	even	after	the	introduction	of	a	control	diet,	once	established	in	recipient	mice,	microbiome	signatures	persisted	and	were
durable.	Consistent	with	our	experiments,	studies	by	Thaiss	et	al66	demonstrated	that	HFD-induced	changes	in	the	gut	microbial	community	structure	persisted	for	months,	even	if	cycles	of	HFD	feeding	were	interspersed	with	periods
of	low-fat	diets.	In	light	of	these	findings,	postdieting	microbiome	alterations	and	associated	dietary-induced	losses	in	key	microbial	functions	might	be	difficult	to	reverse,	with	potentially	profound	consequences	for	host	immunity	and
metabolism.67,68
In	addition	 to	 identifying	 that	HFD	promotes	 intestinal	dysbiosis,	we	 found	 that	 transfer	of	an	HFD-specific	microbiota	also	conferred	enhanced	susceptibility	of	 food	allergy	 in	microbiota	 replete	GF	mice.	Strikingly,	 this
process	occurred	independently	of	any	signs	of	adiposity	in	recipient	mice.	These	findings	strongly	suggest	that	dietary	alteration	alone	is	sufficient	to	drive	microbiota-dependent	effects	on	the	intestinal	immune	system	independently
of	host	metabolic	derangement.	 It	 is	 important	to	note	that	studies	by	Turnbaugh	et	al17,18	 reported	that	 transplantation	of	a	Western	diet–associated	gut	microbiome	 into	GF	mice	 increased	total	body	fat	and	resulted	 in	signs	of
adiposity.	 In	our	experimental	settings	 transfer	of	HFD-associated	microbiota	did	not	reveal	an	obese	phenotype	 in	GF	mice.	Given	the	complexity	of	microbiome	studies,	differences	 in	 founder	colonies	and	colonization	protocols
(cohousing	vs	cecal	microbiota	transplants)	are	likely	to	explain	these	discrepancies.	Notwithstanding	this,	future	studies	will	be	required	to	define	which	microbial	populations	specifically	promote	obesity,	whereas	others	promote
allergic	susceptibility.
Previous	work	and	our	studies	herein	suggest	that	HFD	feeding	and	induction	of	experimental	food	allergy	promote	intestinal	permeabilization,	with	potential	widespread	consequences	for	host	metabolism	and	immunity.3
Although	our	findings	demonstrate	that	HFD	feeding	induces	a	microbiota	signature	that	promotes	food	allergy	susceptibility,	no	significant	alterations	in	expression	levels	for	barrier-related	genes	were	observed	in	GF-replete	mice
with	 food	allergy	colonized	with	an	HFD-associated	microbiome	compared	with	control	mice	 (see	Fig	E7	 in	 this	article's	Online	Repository	at	www.jacionline.org).	 It	 is	 likely	 that	 intestinal	barrier	 integrity	 in	 response	 to	a	HFD-
associated	microbiome	is	transiently	regulated,	and	therefore	no	significant	alterations	at	the	assessed	time	points	are	observed.	Alternatively,	increased	allergy	susceptibility	in	HFD	microbiota–replete	GF	mice	might	not	be	directly
related	to	alterations	in	intestinal	barrier	integrity.	Additional	studies	are	required	to	assess	a	correlation	between	food	allergy	susceptibility	and	intestinal	barrier	function	in	response	to	an	HFD-associated	microbiome.
Although	the	microbial	community	structure	in	recipient	GF	mice	differed	between	experiments,	 likely	because	of	 individual	donor	microbiomes,	 increased	susceptibility	to	experimental	food	allergy	was	conserved	in	HFD
microbiota–replete	GF	mice	across	experiments.	Although	we	 find	differences	 in	 total	OTU	numbers	between	experimental	 replicates	as	a	 likely	 result	of	differences	 in	 survival	of	 reinoculated	bacteria,	a	uniform	pattern	 toward
recovery	 of	 the	 community	 structure	 is	 observed	 across	 experiments.	 After	 comparing	 results	 from	 individual	 microbiota	 transplantation	 experiments,	 we	 consistently	 identified	members	 of	 the	 family	 Lachnospiraceae	 and	 the
Rikenellaceae	 RC9	 groups	 to	 be	 overrepresented	 in	microbiota	 replete	GF	mice	 colonized	with	 an	HFD-associated	 gut	microbiome,	whereas	members	 of	 the	 family	Muribaculaceae	 and	 the	 Prevotellaceae	 group	UCG-001	were
underrepresented	compared	with	control	mice.	Although	it	is	tempting	to	propose	individual	roles	for	OTUs,	it	is	likely	that	the	differential	effect	over	the	immune	system	varies	between	strains	and	that	the	same	response	can	be
caused	by	different	 strains	 from	different	 taxonomic	backgrounds.	Alternatively,	a	decrease	 in	overall	microbial	diversity	as	a	 result	of	prolonged	high-fat	dieting	 rather	 than	overrepresentation	or	underrepresentation	of	 specific
bacterial	strains	might	be	sufficient	to	favor	allergic	inflammation.	Consistent	with	this	hypothesis,	GF	mice	or	mice	harboring	a	reduced	gut	microbial	community	structure	(eg,	ASF	mice,	antibiotic	treated	mice)	are	more	susceptible
to	allergic	inflammation.	Importantly,	restoration	of	gut	microbial	complexity	has	proved	sufficient	to	limit	hyper-IgE	responses	and	allergic	inflammation.15,63,64	However,	it	remains	to	be	tested	whether	restoring	an	HFD-mediated
decrease	 in	microbial	 diversity	with	 fecal	microbiota	 transplants	 from	control	 diet–fed	donors	 or	 by	 reconstitution	with	 selected	microbial	 strains	might	 alter	 food	 allergy	 susceptibility.	Despite	 the	profound	effect	 of	 diet	 on	gut
bacterial	 community	 structure,	 future	 work	 should	 also	 track	 changes	 in	 interkingdom	 relationships	 on	 dietary	 manipulations	 because	 disruption	 of	 the	 mycobiome	 has	 been	 associated	 with	 increased	 susceptibility	 to	 allergic
inflammation.69,70
In	conclusion,	our	study	identifies	HFD-induced	microbial	alterations	as	a	risk	factor	for	experimental	food	allergy	and	uncouples	a	pathogenic	role	of	an	HFD-associated	microbiome	from	obesity.	Restoring	microbial	diversity
in	children	on	a	Western	diet	might	represent	a	promising	approach	to	limit	allergy	susceptibility	in	genetically	predisposed	subjects.
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Appendix
Fig	E1	Assessment	of	diet-induced	obesity.	A,	Percentage	weight	gain	in	response	to	HFD	feeding	over	time.	B,	Body	weight.	C,	Weight	of	epididymal	fat	pads.	D,	Fasting	blood	glucose	levels.	Data	are	representative	of	4	independent	experiments	with	4	to
6	mice	per	group.	Error	bars	indicate	means	±	SEMs.	*P	<	.05,	**P	<	.01,	***P	<	.005,	and	****P	<	.001.
Fig	E2	Food	allergy	induction	in	mice	fed	an	HFD	or	a	matched	control	diet.	A,	Experimental	protocol.	i.g.,	Intragastric.	B,	Clinical	allergy	score	of	control	mice	and	mice	with	food	allergy	fed	a	matched	control	diet	or	an	HFD.	C,	Serum	MMCP-1	levels.
Data	are	representative	of	2	independent	experiments	with	4	to	5	mice	per	group.	Solid	bars	represent	mice	fed	a	matched	control	diet,	and	open	bars	represent	HFD-fed	mice.	Error	bars	indicate	means	±	SEMs.	ND,	No	disease.	**P	<	.01	and	***P	<	.005.
Fig	E3	Changes	in	gut	microbial	community	structure	in	response	to	an	HFD.	A,	Bacterial	relative	abundances	represented	at	the	family	level.	B,	OTUs	that	show	significant	differences	in	abundance	across	treatments,	according	to	the	Welch	2-sided	test.
OTUs	shown	all	have	P	values	of	less	than	.05	(corrected	with	the	Storey	false	discovery	rate)	and	large	effect	sizes	(differences	between	proportions	>	1	and	ratios	between	proportions	>	2).	FA,	▪▪▪food	allergy.
Fig	E4	Changes	in	gut	microbial	community	structure	at	the	OTU,	genus,	and	family	levels	in	microbiota-replete	GF	mice,	according	to	the	Welch	2-sided	test.	Only	differences	with	large	effect	sizes	(differences	between	proportions	>	1	and	ratios	between
proportions	>	2)	are	shown.
Fig	E5	An	HFD-associated	microbiome	does	not	promote	weight	gain.	A,	Percentage	body	weight	gain	of	GF	mice	reconstituted	with	an	SCD-	or	HFD-associated	microbiome.	B,	Body	weight.	C,	Weight	of	epididymal	fat	pads.	Data	are	representative	of	2
independent	experiments	with	4	to	5	mice	per	group.	Solid	bars	represent	GF	mice	reconstituted	with	an	SCD-associated	microbiome,	and	open	bars	represent	HFD	microbiome–reconstituted	mice.	Error	bars	indicate	means	±	SEMs.	ns,	Not	significant.
Table	E1	Description	of	clinical	allergy	score
Score Description
Scratching
 0 No	symptoms
 1 Mild	scratching;	rubbing	of	nose,	head,	or	feet	(<5	episodes)
 2 Intermediate	scratching;	rubbing	of	nose,	head,	or	feet	(>5	to	<10	episodes)
 3 Severe	scratching	(>10	episodes)
Behavior
 0 Normal
 1 Hyperactivity
 2 Aggressive	behavior;	pain	loud	after	prodding
Fig	E6	Assessment	of	MCps	in	WAT	of	SCD	or	HFD	fed	mice.	A,	Representative	flow	cytometric	plots	of	MCps	in	WAT	of	control	mice	or	mice	with	food	allergy	fed	an	SCD	or	HFD.	eWAT,	Epididymal	WAT.	B,	WAT	MCp	numbers.	Data	are	representative	of	2
individual	experiment	with	3	to	5	mice	per	group.	Error	bars	indicate	means	±	SEMs.	**P	≤	.01.
Fig	E7	Gene	expression	levels	for	intestinal	barrier–associated	genes	in	microbiome-replete	mice	with	food	allergy.	Gene	expression	levels	of	Ocln	(A),	Tjp1	(B),	and	Cldn2	(C)	in	the	small	intestines	of	microbiota-replete	GF	mice	with	food	allergy.	Data	are
representative	of	2	independent	experiments	with	4	mice	per	group.	Solid	bars	represent	GF	mice	with	food	allergy	reconstituted	with	an	SCD-associated	microbiome,	and	open	bars	represent	HFD	microbiome–reconstituted	mice	with	food	allergy.	Error
bars	indicate	means	±	SEMs.
Queries	and	Answers
Query:	If	there	are	any	drug	dosages	in	your	article,	please	verify	them	and	indicate	that	you	have	done	so	by	initialing	this	query
Answer:	does	not	apply
Query:	Please	verify	that	WAT	is	spelled	out	correctly	here	as	“white	adipose	tissue.”
Answer:	correct
Query:	Please	clarify	the	“Kit	protocol.”	Should	this	have	a	citation	or	manufacturer’s	information?
Answer:	QIAmp	Fast	DNA	Stool	Kit,	Qiagen
Query:	Please	verify	that	data	on	quality	filtering	of	raw	reads	is	presented	clearly	and	completely	as	shown	(ie,	please	spell	out	“-p,”	“-m,”	etc).	Also,	if	applicable,	please	provide	a	citation	for	Zhang
et	al,	citing	it	in	numeric	order	and	renumbering	all	subsequent	citations	throughout.
Answer:	Raw	reads	were	quality-filtered	with	FastX-Tookit	(a	minimum	quality	score	of	33	kept	across	75%	of	the	bases),	merged	with	PEAR	(with	a	maximum	possible	length	of	merged	reads	of	360,
minimum	possible	length	of	merged	reads	of	100,	score	quality	threshold	for	trimming	of	26,	minimum	overlap	size	of	50,	and	a	base	PHRED	quality	score	of	33
Query:	Please	spell	out	ADONIS	and	ANOSIM	throughout,	if	applicable.
Answer:	These	are	standard	statistical	tests!
Query:	Please	note	that	P	values	indicated	by	asterisks	have	been	moved	to	figure	legends	per	journal	style.	Please	check	carefully.
Answer:	ok
Physical	appearance
 0 Normal	activity
 2 Significantly	reduced	mobility;	piloerection
 3 Immobility	after	prodding,	tremors,	and/or	significant	respiratory	distress
Stool	consistency
 0 Normal
 2 Loose	stool
 4 Diarrhea
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Query:	Please	provide	volume	number	for	reference	46.
Answer:	No	volume	number	found	either!
Query:	Please	provide	volume	and	page	numbers	for	reference	56.	It	does	not	appear	in	PubMed.
Answer:	Reference	replaced
Query:	Please	spell	out	FA	in	the	legend	fir	Fig	E3.
Answer:	FA:	food	allergy
Query:	Have	we	correctly	interpreted	the	following	funding	source(s)	and	country	names	you	cited	in	your	article:	Human	Frontier	Science	Program,	France;	Fondation	Acteria,	Switzerland;	European
Research	Council,	European	Union?
Answer:	Yes
Query:	Please	confirm	that	given	names	and	surnames	have	been	identified	correctly	and	are	presented	in	the	desired	order	and	please	carefully	verify	the	spelling	of	all	authors’	names.
Answer:	Yes
